Optimizing	0	10	O
treatment	11	20	O
of	21	23	O
choroidal	24	33	O
neovascularization	34	52	O
feeder	53	59	B-Multi-tissue_structure
vessels	60	67	I-Multi-tissue_structure
associated	68	78	O
with	79	83	O
age	84	87	O
-	87	88	O
related	88	95	O
macular	96	103	B-Tissue
degeneration	104	116	O
.	116	117	O

PURPOSE	119	126	O
:	126	127	O
To	128	130	O
optimize	131	139	O
the	140	143	O
method	144	150	O
of	151	153	O
treating	154	162	O
choroidal	163	172	O
neovascularization	173	191	O
(	192	193	O
CNV	193	196	O
)	196	197	O
associated	198	208	O
with	209	213	O
age	214	217	O
-	217	218	O
related	218	225	O
macular	226	233	B-Tissue
degeneration	234	246	O
(	247	248	O
AMD	248	251	O
)	251	252	O
.	252	253	O

DESIGN	254	260	O
:	260	261	O
Experimental	262	274	O
study	275	280	O
and	281	284	O
interventional	285	299	O
case	300	304	O
series	305	311	O
.	311	312	O

METHODS	313	320	O
:	320	321	O
The	322	325	O
parameters	326	336	O
associated	337	347	O
with	348	352	O
locating	353	361	O
and	362	365	O
then	366	370	O
photocoagulating	371	387	O
CNV	388	391	O
feeder	392	398	B-Multi-tissue_structure
vessels	399	406	I-Multi-tissue_structure
were	407	411	O
identified	412	422	O
and	423	426	O
optimized	427	436	O
using	437	442	O
published	443	452	O
data	453	457	O
and	458	461	O
data	462	466	O
derived	467	474	O
from	475	479	O
modeling	480	488	O
the	489	492	O
choroidal	493	502	B-Multi-tissue_structure
vasculature	503	514	I-Multi-tissue_structure
.	514	515	O

Based	516	521	O
on	522	524	O
these	525	530	O
optimized	531	540	O
parameters	541	551	O
,	551	552	O
a	553	554	O
prototype	555	564	O
diagnostic	565	575	O
/	575	576	O
treatment	576	585	O
system	586	592	O
was	593	596	O
designed	597	605	O
that	606	610	O
captures	611	619	O
high	620	624	O
-	624	625	O
speed	625	630	O
indocyanine	631	642	B-Drug_or_compound
green	643	648	I-Drug_or_compound
(	649	650	O
ICG	650	653	B-Drug_or_compound
)	653	654	O
angiogram	655	664	O
images	665	671	O
and	672	675	O
facilitates	676	687	O
analysis	688	696	O
of	697	699	O
the	700	703	O
images	704	710	O
by	711	713	O
enhancing	714	723	O
visualization	724	737	O
of	738	740	O
dye	741	744	O
movement	745	753	O
through	754	761	O
CNV	762	765	O
feeder	766	772	B-Multi-tissue_structure
vessels	773	780	I-Multi-tissue_structure
(	781	782	O
FVs	782	785	B-Multi-tissue_structure
)	785	786	O
.	786	787	O

The	788	791	O
system	792	798	O
also	799	803	O
permits	804	811	O
precise	812	819	O
aiming	820	826	O
and	827	830	O
delivery	831	839	O
of	840	842	O
810	843	846	O
-	846	847	O
nm	848	850	O
wavelength	851	861	O
photocoagulation	862	878	O
laser	879	884	O
energy	885	891	O
to	892	894	O
target	895	901	O
FVs	902	905	B-Multi-tissue_structure
on	906	908	O
a	909	910	O
real	911	915	O
-	915	916	O
time	916	920	O
ICG	921	924	B-Drug_or_compound
angiogram	925	934	O
image	935	940	O
of	941	943	O
the	944	947	O
choroidal	948	957	B-Multi-tissue_structure
vasculature	958	969	I-Multi-tissue_structure
.	969	970	O

Target	971	977	O
FVs	978	981	B-Multi-tissue_structure
are	982	985	O
tracked	986	993	O
by	994	996	O
a	997	998	O
joy	999	1002	O
-	1002	1003	O
stick	1003	1008	O
controlled	1009	1019	O
laser	1020	1025	O
aiming	1026	1032	O
beam	1033	1037	O
until	1038	1043	O
an	1044	1046	O
intravenously	1047	1060	O
-	1060	1061	O
injected	1061	1069	O
high	1070	1074	O
-	1074	1075	O
concentration	1075	1088	O
ICG	1089	1092	B-Drug_or_compound
dye	1093	1096	I-Drug_or_compound
bolus	1097	1102	O
is	1103	1105	O
observed	1106	1114	O
to	1115	1117	O
enter	1118	1123	O
the	1124	1127	O
target	1128	1134	O
vessel	1135	1141	B-Multi-tissue_structure
,	1141	1142	O
at	1143	1145	O
which	1146	1151	O
time	1152	1156	O
the	1157	1160	O
laser	1161	1166	O
is	1167	1169	O
fired	1170	1175	O
.	1175	1176	O

Proof	1177	1182	O
of	1183	1185	O
principle	1186	1195	O
of	1196	1198	O
the	1199	1202	O
combined	1203	1211	O
diagnosis	1212	1221	O
/	1221	1222	O
treatment	1222	1231	O
system	1232	1238	O
design	1239	1245	O
for	1246	1249	O
performing	1250	1260	O
dye	1261	1264	O
-	1264	1265	O
enhanced	1265	1273	O
photocoagulation	1274	1290	O
(	1291	1292	O
DEP	1292	1295	O
)	1295	1296	O
in	1297	1299	O
the	1300	1303	O
clinical	1304	1312	O
setting	1313	1320	O
and	1321	1324	O
determination	1325	1338	O
of	1339	1341	O
the	1342	1345	O
minimum	1346	1353	O
DEP	1354	1357	O
laser	1358	1363	O
energy	1364	1370	O
needed	1371	1377	O
to	1378	1380	O
close	1381	1386	O
CNV	1387	1390	O
FVs	1391	1394	B-Multi-tissue_structure
was	1395	1398	O
made	1399	1403	O
in	1404	1406	O
11	1407	1409	O
AMD	1410	1413	O
patients	1414	1422	B-Organism
requiring	1423	1432	O
treatment	1433	1442	O
of	1443	1445	O
CNV	1446	1449	O
,	1449	1450	O
but	1451	1454	O
for	1455	1458	O
whom	1459	1463	O
other	1464	1469	O
treatment	1470	1479	O
was	1480	1483	O
not	1484	1487	O
appropriate	1488	1499	O
.	1499	1500	O

RESULTS	1501	1508	O
:	1508	1509	O
Using	1510	1515	O
ICG	1516	1519	B-Drug_or_compound
-	1519	1520	O
DEP	1520	1523	O
,	1523	1524	O
CNV	1525	1528	O
feeder	1529	1535	B-Multi-tissue_structure
vessels	1536	1543	I-Multi-tissue_structure
were	1544	1548	O
closed	1549	1555	O
with	1556	1560	O
single	1561	1567	O
pulse	1568	1573	O
laser	1574	1579	O
energy	1580	1586	O
,	1586	1587	O
delivering	1588	1598	O
as	1599	1601	O
little	1602	1608	O
as	1609	1611	O
0	1612	1613	O
.	1613	1614	O
6	1614	1615	O
to	1616	1618	O
1	1619	1620	O
.	1620	1621	O
8	1621	1622	O
J	1623	1624	O
of	1625	1627	O
energy	1628	1634	O
to	1635	1637	O
the	1638	1641	O
fundus	1642	1648	B-Multi-tissue_structure
,	1648	1649	O
producing	1650	1659	O
no	1660	1662	O
visible	1663	1670	O
change	1671	1677	O
in	1678	1680	O
the	1681	1684	O
fundus	1685	1691	B-Multi-tissue_structure
.	1691	1692	O

Successful	1693	1703	O
FV	1704	1706	B-Multi-tissue_structure
closure	1707	1714	O
was	1715	1718	O
usually	1719	1726	O
indicated	1727	1736	O
immediately	1737	1748	O
by	1749	1751	O
presence	1752	1760	O
of	1761	1763	O
incarcerated	1764	1776	O
ICG	1777	1780	B-Drug_or_compound
dye	1781	1784	I-Drug_or_compound
in	1785	1787	O
the	1788	1791	O
vessel	1792	1798	B-Multi-tissue_structure
adjacent	1799	1807	O
to	1808	1810	O
the	1811	1814	O
burn	1815	1819	O
site	1820	1824	O
.	1824	1825	O

The	1826	1829	O
prototype	1830	1839	O
system	1840	1846	O
proved	1847	1853	O
relatively	1854	1864	O
easy	1865	1869	O
to	1870	1872	O
operate	1873	1880	O
.	1880	1881	O

After	1882	1887	O
acquiring	1888	1897	O
and	1898	1901	O
interpreting	1902	1914	O
diagnostic	1915	1925	O
angiograms	1926	1936	O
and	1937	1940	O
repositioning	1941	1954	O
a	1955	1956	O
patient	1957	1964	B-Organism
in	1965	1967	O
front	1968	1973	O
of	1974	1976	O
the	1977	1980	O
device	1981	1987	O
,	1987	1988	O
feeder	1989	1995	B-Multi-tissue_structure
vessel	1996	2002	I-Multi-tissue_structure
DEP	2003	2006	O
and	2007	2010	O
treatment	2011	2020	O
evaluation	2021	2031	O
required	2032	2040	O
15	2041	2043	O
to	2044	2046	O
20	2047	2049	O
minutes	2050	2057	O
.	2057	2058	O

CONCLUSIONS	2059	2070	O
:	2070	2071	O
Indocyanine	2072	2083	B-Drug_or_compound
green	2084	2089	I-Drug_or_compound
dye	2090	2093	I-Drug_or_compound
-	2093	2094	O
enhanced	2094	2102	O
photocoagulation	2103	2119	O
of	2120	2122	O
CNV	2123	2126	O
feeder	2127	2133	B-Multi-tissue_structure
vessels	2134	2141	I-Multi-tissue_structure
,	2141	2142	O
facilitated	2143	2154	O
by	2155	2157	O
use	2158	2161	O
of	2162	2164	O
a	2165	2166	O
device	2167	2173	O
that	2174	2178	O
permits	2179	2186	O
real	2187	2191	O
-	2191	2192	O
time	2192	2196	O
visualization	2197	2210	O
of	2211	2213	O
the	2214	2217	O
choroidal	2218	2227	O
circulation	2228	2239	O
while	2240	2245	O
aiming	2246	2252	O
the	2253	2256	O
treatment	2257	2266	O
laser	2267	2272	O
beam	2273	2277	O
,	2277	2278	O
appears	2279	2286	O
to	2287	2289	O
minimize	2290	2298	O
the	2299	2302	O
amount	2303	2309	O
of	2310	2312	O
energy	2313	2319	O
applied	2320	2327	O
to	2328	2330	O
the	2331	2334	O
fundus	2335	2341	B-Multi-tissue_structure
and	2342	2345	O
the	2346	2349	O
volume	2350	2356	O
of	2357	2359	O
fundus	2360	2366	B-Tissue
tissue	2367	2373	I-Tissue
affected	2374	2382	O
by	2383	2385	O
treatment	2386	2395	O
,	2395	2396	O
compared	2397	2405	O
with	2406	2410	O
other	2411	2416	O
treatment	2417	2426	O
modalities	2427	2437	O
.	2437	2438	O

The	2439	2442	O
combination	2443	2454	O
diagnosis	2455	2464	O
/	2464	2465	O
treatment	2465	2474	O
device	2475	2481	O
should	2482	2488	O
be	2489	2491	O
useful	2492	2498	O
in	2499	2501	O
optimizing	2502	2512	O
FV	2513	2515	B-Multi-tissue_structure
treatment	2516	2525	O
and	2526	2529	O
in	2530	2532	O
refining	2533	2541	O
and	2542	2545	O
evaluating	2546	2556	O
the	2557	2560	O
efficacy	2561	2569	O
of	2570	2572	O
DEP	2573	2576	O
in	2577	2579	O
future	2580	2586	O
clinical	2587	2595	O
trials	2596	2602	O
.	2602	2603	O

